(Q34074851)

30 July 2017

1 reference

title

Cyclosporin treatment of glomerular diseases (English)

1 reference

30 July 2017

Radhakrishnan J

1

1 reference

30 July 2017

Halevy D

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

1053-1063

1 reference

Mechanisms of proteinuria in noninflammatory glomerular diseases

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Cyclosporine A induced remission of relapsing nephrotic syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Treatment of the nephrotic syndrome associated with primary glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

A review of therapeutic studies of idiopathic membranous glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Long-term follow up of renal function in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Corticosteroids in IgA nephropathy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Treatment of lupus nephritis: a meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Effects of cyclosporine in severe systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.5.1053

10.1517/13543784.9.5.1053

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference